DCM
FOLD

Driehaus Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Driehaus Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-16,502
Closed -$166K – 516
2017
Q2 		$166K Buy
+16,502
New +$133K 0.01% 521
2015
Q4 		– Sell
-38,807
Closed -$543K – 573
2015
Q3 		$543K Buy
38,807
+13,848
+55% +$217K 0.02% 421
2015
Q2 		$353K Buy
+24,959
New +$300K 0.01% 479
2013
Q4 		– Sell
-134,593
Closed -$312K – 484
2013
Q3 		$312K Hold
134,593
– – 0.01% 415
2013
Q2 		$314K Buy
+134,593
New +$414K 0.01% 410

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Driehaus Capital Management's FOLD Position: Q3 2017 in Review

Driehaus Capital Management sold out of Amicus Therapeutics (FOLD) in Q3 2017, closing a stake of 16,502 shares — an estimated $166K sold.

Driehaus Capital Management first reported a position in FOLD in Q2 2013 and held it in 5 quarters. The position peaked at $543K in Q3 2015. 186 funds tracked by Wall St. Rank hold FOLD as of Q3 2017.

  • Driehaus Capital Management reported no remaining Amicus Therapeutics position as of Q3 2017 after selling out during the quarter.
  • Driehaus Capital Management sold 16,502 Amicus Therapeutics shares in Q3 2017, an estimated $166K.
  • Driehaus Capital Management first reported a position in Amicus Therapeutics in Q2 2013 and held it in 5 quarters.
  • Driehaus Capital Management's Amicus Therapeutics position peaked at $543K in Q3 2015.
  • 186 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2017.

Based on Driehaus Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.